advertisement

Topcon

Li Y 11

Showing records 1 to 11 | Display all abstracts from Li Y

85069 Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
Zheng M
Experimental and therapeutic medicine 2020; 19: 1329-1335
84677 Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy
Sun C; Zhang H
International Ophthalmology 2020; 40: 467-475
85069 Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
Zheng Y
Experimental and therapeutic medicine 2020; 19: 1329-1335
84677 Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy
Jiang J
International Ophthalmology 2020; 40: 467-475
85069 Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
Gao M; Ma H
Experimental and therapeutic medicine 2020; 19: 1329-1335
84677 Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy
Li Y
International Ophthalmology 2020; 40: 467-475
85069 Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
Zhang X
Experimental and therapeutic medicine 2020; 19: 1329-1335
84677 Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy
Nie C; Gu J
International Ophthalmology 2020; 40: 467-475
85069 Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
Li Y; Wang F
Experimental and therapeutic medicine 2020; 19: 1329-1335
84677 Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy
Luo L; Wang Z
International Ophthalmology 2020; 40: 467-475
85069 Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
Huang H
Experimental and therapeutic medicine 2020; 19: 1329-1335

Issue 21-1

Change Issue


advertisement

Nidek